The most common molecular alterations in papillary thyroid carcinomas are BRAF (62%)—predominantly, BRAFV600E—RAS (13%), RET-PTC (7%), and TERT promoter mutation (9%). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.